Showing results (201-210 of 8,955) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|July 15, 2009
Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and CPaula Bonorino, Muhammad Ramzan, Xavier Camous, et al.Journal of Hepatology|July 15, 2009
Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 proteinCristina Mansilla, Marta Gorraiz, Marta Martinez, et al.Journal of Hepatology|December 20, 2011
Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trialZahid Azam, Saeed Hamid, Wasim Jafri, et al.Journal of Hepatology|December 20, 2011
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migrationGarrick K Wilson, Claire L Brimacombe, Ian A Rowe, et al.Journal of Hepatology|February 14, 2012
Adult hepatoblastoma: learning from childrenAnne-Laure Rougemont, Valérie A McLin, Christian Toso, et al.Journal of Hepatology|February 14, 2012
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver diseaseDerrick E Fouts, Manolito Torralba, Karen E Nelson, et al.Journal of Hepatology|February 14, 2012
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label studyChristophe Moreno, Thomas Berg, Tawesak Tanwandee, et al.Journal of Hepatology|February 21, 2012
EASL Clinical Practice Guidelines: Wilson's diseaseJournal of Hepatology|February 11, 2012
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenibAnja Lachenmayer, Sara Toffanin, Laia Cabellos, et al.Journal of Hepatology|March 15, 2012
Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cellsMarie-José Blivet-Van Eggelpoël, Hamza Chettouh, Laetitia Fartoux, et al.Pageof 896